CIRRHOSIS ASSOCIATED WITH METHOTREXATE TREATMENT OF PSORIASIS

[11] CONDIT PT, 1960, CANCER-AM CANCER SOC, V13, P229, DOI 10.1002/1097-0142(196003/04)13:2&lt

[12] 229::AID-CNCR2820130204&gt

[13] 3.0.CO

[14] 2-M

[15] FERGUSON FC, 1950, J PHARMACOL EXP THER, V98, P293

[16] FOUNTAIN JR, 1953, P SOC EXP BIOL MED, V83, P369, DOI 10.3181/00379727-83-20362

[17] HERSH EM, 1966, CANCER, V19, P600, DOI 10.1002/1097-0142(196604)19:4<600::AID-CNCR2820190420>3.0.CO

[18] 2-3

[19] HITZIG VWH, 1960, HELV PAEDIATR ACTA, V15, P235

[20] HUTTER RVP, 1960, CANCER, V13, P288, DOI 10.1002/1097-0142(196003/04)13:2<288::AID-CNCR2820130213>3.0.CO

[11] CONDIT PT, 1960, CANCER-AM CANCER SOC, V13, P229, DOI 10.1002/1097-0142(196003/04)13:2&lt

[12] 229::AID-CNCR2820130204&gt

[13] 3.0.CO

[14] 2-M

[15] FERGUSON FC, 1950, J PHARMACOL EXP THER, V98, P293

[16] FOUNTAIN JR, 1953, P SOC EXP BIOL MED, V83, P369, DOI 10.3181/00379727-83-20362

[17] HERSH EM, 1966, CANCER, V19, P600, DOI 10.1002/1097-0142(196604)19:4<600::AID-CNCR2820190420>3.0.CO

[18] 2-3

[19] HITZIG VWH, 1960, HELV PAEDIATR ACTA, V15, P235

[20] HUTTER RVP, 1960, CANCER, V13, P288, DOI 10.1002/1097-0142(196003/04)13:2<288::AID-CNCR2820130213>3.0.CO